These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31900196)

  • 1. Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells.
    Sharda A; Rashid M; Shah SG; Sharma AK; Singh SR; Gera P; Chilkapati MK; Gupta S
    Clin Epigenetics; 2020 Jan; 12(1):4. PubMed ID: 31900196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic histone acetylation and Bdnf dysregulation in the hippocampus of rats exposed to repeated, low-dose diisopropylfluorophosphate.
    Ribeiro ACR; Jahr FM; Hawkins E; Kronfol MM; Younis RM; McClay JL; Deshpande LS
    Life Sci; 2021 Sep; 281():119765. PubMed ID: 34186043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells.
    Bhat J; Dubin S; Dananberg A; Quabius ES; Fritsch J; Dowds CM; Saxena A; Chitadze G; Lettau M; Kabelitz D
    Front Immunol; 2019; 10():569. PubMed ID: 30972064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities.
    Dedes KJ; Dedes I; Imesch P; von Bueren AO; Fink D; Fedier A
    Anticancer Drugs; 2009 Jun; 20(5):321-33. PubMed ID: 19322073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition.
    Davis MR; Daggett JJ; Pascual AS; Lam JM; Leyva KJ; Cooper KE; Hull EE
    BMC Cancer; 2016 May; 16():316. PubMed ID: 27188282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
    Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B
    Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells.
    Ganai SA; Kalladi SM; Mahadevan V
    J Biomol Struct Dyn; 2015; 33(6):1185-97. PubMed ID: 25012937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
    Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
    Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
    Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
    J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. `Up-regulation of histone acetylation induced by social defeat mediates the conditioned rewarding effects of cocaine.
    Montagud-Romero S; Montesinos J; Pascual M; Aguilar MA; Roger-Sanchez C; Guerri C; Miñarro J; Rodríguez-Arias M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():39-48. PubMed ID: 27180319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
    Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT
    Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of histone acetylation in SMN gene expression.
    Kernochan LE; Russo ML; Woodling NS; Huynh TN; Avila AM; Fischbeck KH; Sumner CJ
    Hum Mol Genet; 2005 May; 14(9):1171-82. PubMed ID: 15772088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study.
    Chavez-Blanco A; Segura-Pacheco B; Perez-Cardenas E; Taja-Chayeb L; Cetina L; Candelaria M; Cantu D; Gonzalez-Fierro A; Garcia-Lopez P; Zambrano P; Perez-Plasencia C; Cabrera G; Trejo-Becerril C; Angeles E; Duenas-Gonzalez A
    Mol Cancer; 2005 Jul; 4(1):22. PubMed ID: 16001982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epigenetic changes are affected by sex and valproic acid treatment in a rat model of post-traumatic stress disorder.
    Akpınar G; Ketenci S; Sarıdoğan GE; Aydın B; Tekin N; Cabadak H; Zafer Gören M
    Neurosci Lett; 2024 Sep; 839():137957. PubMed ID: 39218294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
    Santini V; Gozzini A; Ferrari G
    Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.